Microlink Solutions Berhad (KLSE:MICROLN)
0.1200
0.00 (0.00%)
At close: Aug 1, 2025
Verve Therapeutics Cash Flow Statement
Financials in millions MYR. Fiscal year is April - March.
Millions MYR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | -92.17 | -26.84 | 25.86 | 25.47 | 31.76 | Upgrade |
Depreciation & Amortization | 1.59 | 1.18 | 1.49 | 1.45 | 1.16 | Upgrade |
Other Amortization | 4.17 | 14.17 | 12.88 | 7.82 | 1.94 | Upgrade |
Loss (Gain) From Sale of Assets | -3.11 | 0 | - | - | -0.09 | Upgrade |
Asset Writedown & Restructuring Costs | 81.98 | - | - | - | -38.74 | Upgrade |
Loss (Gain) From Sale of Investments | - | -1.01 | -3.25 | -1.95 | - | Upgrade |
Loss (Gain) on Equity Investments | - | - | -0.28 | - | - | Upgrade |
Stock-Based Compensation | - | - | 4.36 | 2.94 | 2.67 | Upgrade |
Provision & Write-off of Bad Debts | - | 10.44 | -0.2 | -0.27 | 10.03 | Upgrade |
Other Operating Activities | 8.73 | 1.25 | -5.25 | 2.84 | 1.52 | Upgrade |
Change in Accounts Receivable | - | -41.1 | -22.75 | -15.47 | 35.46 | Upgrade |
Change in Inventory | - | -17.43 | -16.51 | 0.86 | 0.41 | Upgrade |
Change in Accounts Payable | - | 37.84 | -0.51 | 6.26 | -28.54 | Upgrade |
Change in Unearned Revenue | - | -6.63 | 8.73 | -0.4 | -10.75 | Upgrade |
Change in Other Net Operating Assets | -18.63 | 0.16 | 0.13 | 4.07 | -2 | Upgrade |
Operating Cash Flow | -17.43 | -27.96 | 4.7 | 33.62 | 4.81 | Upgrade |
Operating Cash Flow Growth | - | - | -86.02% | 599.21% | -79.14% | Upgrade |
Capital Expenditures | -9.64 | -1.78 | -0.45 | -0.17 | -0.19 | Upgrade |
Sale of Property, Plant & Equipment | - | 0 | - | - | 0.19 | Upgrade |
Cash Acquisitions | - | 0.01 | -0.04 | - | - | Upgrade |
Sale (Purchase) of Intangibles | - | -2.99 | -22.36 | -46.93 | -23.54 | Upgrade |
Sale (Purchase) of Real Estate | - | - | -6 | - | - | Upgrade |
Investment in Securities | 0.09 | 4.31 | 4.33 | -2.42 | 0.01 | Upgrade |
Other Investing Activities | -3.28 | -1.94 | -0.41 | 11.42 | -36.05 | Upgrade |
Investing Cash Flow | -12.83 | -2.38 | -24.93 | -38.11 | -59.59 | Upgrade |
Short-Term Debt Issued | 34.53 | 13.23 | 0.09 | 89.44 | 6.69 | Upgrade |
Long-Term Debt Issued | 0.14 | - | - | - | - | Upgrade |
Total Debt Issued | 34.67 | 13.23 | 0.09 | 89.44 | 6.69 | Upgrade |
Short-Term Debt Repaid | - | - | - | -81.54 | - | Upgrade |
Long-Term Debt Repaid | - | -2.31 | -3.37 | -3.67 | -6.46 | Upgrade |
Total Debt Repaid | - | -2.31 | -3.37 | -85.21 | -6.46 | Upgrade |
Net Debt Issued (Repaid) | 34.67 | 10.92 | -3.28 | 4.23 | 0.23 | Upgrade |
Issuance of Common Stock | - | - | - | 53.37 | 50.08 | Upgrade |
Common Dividends Paid | - | - | -5.34 | - | -3.7 | Upgrade |
Other Financing Activities | -4.21 | -2.71 | -1.34 | -1.12 | -1.37 | Upgrade |
Financing Cash Flow | 30.46 | 8.21 | -9.96 | 56.48 | 45.24 | Upgrade |
Foreign Exchange Rate Adjustments | -1.04 | -0.28 | -0.21 | 0.04 | 0.05 | Upgrade |
Net Cash Flow | -0.85 | -22.41 | -30.41 | 52.03 | -9.5 | Upgrade |
Free Cash Flow | -27.07 | -29.74 | 4.25 | 33.45 | 4.62 | Upgrade |
Free Cash Flow Growth | - | - | -87.29% | 624.73% | -79.89% | Upgrade |
Free Cash Flow Margin | -7.50% | -10.57% | 1.71% | 15.32% | 2.59% | Upgrade |
Free Cash Flow Per Share | -0.03 | -0.03 | 0.00 | 0.05 | 0.01 | Upgrade |
Cash Interest Paid | 4.21 | 2.71 | 1.11 | 1.12 | 1.37 | Upgrade |
Cash Income Tax Paid | -1.11 | 3.78 | 9.99 | 6.08 | 3.24 | Upgrade |
Levered Free Cash Flow | -21.44 | -21.31 | -25.67 | -11.34 | -39.54 | Upgrade |
Unlevered Free Cash Flow | -18.85 | -19.36 | -24.62 | -10.43 | -38.29 | Upgrade |
Change in Net Working Capital | 13.17 | 16.35 | 41.32 | -2.15 | 42.29 | Upgrade |
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.